Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

n. It is designed to instruct the patient’s immune system to produce an antibody response against angiotensin II. Angiotensin II is a small peptide in the body and part of the so-called renin-angiotensin system (RAS), an important regulator of blood pressure. Angiotensin II causes blood vessels to narrow,
resulting in increased blood pressure. In a phase IIa clinical trial, vaccination with CYT006-AngQb has been shown to reduce blood pressure by induction of antibodies that bind angiotensin II. Thereby, binding of angiotensin II to its receptors and subsequent narrowing of blood vessels should be decreased. The RAS has already been successfully targeted by three major classes of antihypertensive drugs on the market: inhibitors of the angiotensin-converting-enzyme (ACE), antagonists of the angiotensin II type I receptor (ARBs) and renin inhibitors. Like other antihypertensive drugs these also come with the need for daily dosing and fail to provide a solution for improving patient compliance. Treatment with CYT006-AngQb should allow for convenient dosing schedules and smooth control of blood pressure due to a sustained antibody response induced by vaccination.



About Cytos Biotechnology AG
Cytos Biotechnology AG is a public Swiss biotechnology company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products – the ImmunodrugsTM. ImmunodrugsTM are intended for use in the treatment and prevention of common chronic diseases, which afflict millions of people worldwide. ImmunodrugsTM are designed to instruct the patient’s immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. Taking advantage of the high flexibility of its ImmunodrugTM platform, Cytos Biotechnology has built a pipeline of different ImmunodrugTM candidates in various disease areas, of which 6 are currently in clinical development. The Imm
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:11/21/2014)...  Alere Inc. (NYSE: ALR ), a ... Juliet Cunningham as Vice President, Investor Relations. In ... driving communications with the investment community. "As ... to increase shareholder value, it is critical that we ... Chief Executive Officer. "We are delighted that Juliet ...
(Date:11/21/2014)... 21, 2014  Tandem Diabetes Care ® , ... device company and manufacturer of the t:slim ® ... Tidepool, a non-profit dedicated to improving diabetes therapy ... that increases diabetes data accessibility. This partnership will ... currently under development, to download and access data ...
(Date:11/21/2014)... SAN MARCOS, Texas , Nov. 21, 2014 /PRNewswire/ ... industrial hemp containing low THC, announces they are now ... is comparable to Charlotte,s Web type strains grown in ... symptoms from other neurological disorders, such as Parkinson,s, MS, ... waiting for US laws to pass, because imported CBD ...
Breaking Medicine Technology:Alere Appoints Juliet Cunningham to Lead Investor Relations 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... The U.S. Food and Drug Administration today approved Soliris ... (aHUS), a rare and chronic blood disease that can ... with increased risk of death and stroke. ... HUS accounts for 5 to 10 percent of all ...
... Internal Fixation Systems, Inc. (OTC QB: IFIX), manufacturer ... podiatric implants announced today that the company has been ...  DTC eligibility allows ownership of the company,s shares to ... Depository Trust Company is a member of the U.S. ...
Cached Medicine Technology:FDA Approves Soliris for Rare Pediatric Blood Disorder 2FDA Approves Soliris for Rare Pediatric Blood Disorder 3Internal Fixation Systems, Inc. Announces DTC Eligibility 2
(Date:11/23/2014)... 2014 Asher Milgrom, is a ... Wellness was recently featured on International Business ... and CEO of American Medical Aesthetics & Wellness, also ... a full scholarship to attend an M.D./Ph.D program at ... the University of Chicago, where his field of study ...
(Date:11/23/2014)... OH (PRWEB) November 23, 2014 Syngenta ... LLC on behalf of farmers and agribusinesses that have ... attempts to commercialize Agrisure Viptera and Agrisure Duracade, ... not been approved for sale in China. According to ... China to virtually ban U.S. corn imports. Because China ...
(Date:11/23/2014)... City, Utah (PRWEB) November 23, 2014 ... health insurance reimbursement for small businesses, announced their ... book, The End of Employer-Provided Health Insurance. ... insurance is the greatest financial risk facing most ... facing U.S. employers, small and large, when it ...
(Date:11/22/2014)... Cancer researchers in New York and Minnesota ... tunnels and the growth and spread of mesothelioma. ... the Surviving Mesothelioma website. , Doctors at Memorial ... have just released their study on tunneling nanotubes (TnTs), ... They found that mesothelioma cells contain many ...
(Date:11/22/2014)... A classic black prom dress will never go out of ... unveiled its new items of black prom gowns . ... big discount, up to 70% off. People throughout the world ... prom dresses, made with the best materials, can make wearers ... customers, the company provides these beautiful outfits in a huge ...
Breaking Medicine News(10 mins):Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2
... Service (ARS) finds that various forms of peanut flour ... to help food experts to improve food textures. ... oil from roasted peanut seeds. It is added to ... dressings to enhance flavor and protein value. ...
... American client who wants to show it in Tokyo in ... all this from Chennai too! ,But a small company ... Specialising in providing software services to the healthcare sector, it ... in millions of dollars in profit. ,Its ...
... in effectiveness to each other but differ when it ... released today by HHS’ Agency for Healthcare Research and ... of nearly 300 published studies of second-generation antidepressants, show ... relief from the drugs. About six in 10 also ...
... that too much alcohol can lead to multiple health ... of this perception.// Many people also assume that a ... probably alcoholics. This may not be accurate. A recent ... that, in fact, most alcohol-related problems may be due ...
... the bacterium that causes pneumonic plague is significantly slowed when ... Washington University School of// Medicine in St. Louis report in ... a primary concern in pneumonic plague, which kills in three ... terrorist attack. The bacterium that causes plague, Yersinia pestis, is ...
... (MS) is a chronic inflammatory disorder that causes degeneration ... leading to various symptoms including muscle// weakness and pain. ... cycles of disease and remission, leading to the suggestion ... inflammation. Using a mouse model of MS (known as ...
Cached Medicine News:Health News:Cashing in on IT for Healthcare 2Health News:Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ 2Health News:Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ 3Health News:Excessive Drinking, Not Alcoholism, may Lead to Most Alcohol-Related Problems 2Health News:Disabling Key Protein may Give Physicians Time to Treat Pneumonic Plague 2
... automated solution for Western Blot analysis ... fully automated Western Blot Analyzer for many ... reveal the presence of infectious diseases such ... fast and accurate screening of allergies and ...
... Advantages of using the Antigen-Antibody Pens-Using a ... and developed specialized fountain pens, called Antigen-Antibody ... or write/mark the blotting membranes in any ... formulated antigen-bonded colored dyes helps to see ...
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
... to 350 Liters of pure water, Complete, ... of Purified Water,Millipores compact S.D.S. Storage and ... to 350 liters of purified water produced ... maintain consistent purity of stored water, provide ...
Medicine Products: